ClinicalTrials.Veeva

Menu

Cardiomyopathy Arrhythmia Risk Evaluation (CARE)

University Health Network, Toronto logo

University Health Network, Toronto

Status

Completed

Conditions

Cardiomyopathy

Study type

Observational

Funder types

Other

Identifiers

NCT02560844
08-0638

Details and patient eligibility

About

This study will evaluate the prognostic utility of novel ECG markers of electrical instability in patients with cardiomyopathy.

Full description

Baseline ECG markers of electrical instability will be measured in patients with cardiomyopathy. These ECG markers will be evaluated from a clinical Holter recording. All patients will have a primary implantable cardioverter defibrillator (ICD) as part of their clinical care. Patients will be followed prospectively for 2 years to evaluate the primary outcome of appropriate ICD shocks. Multivariable modelling will be performed to determine whether the ECG markers of electrical instability independently predict the primary clinical outcome.

Enrollment

164 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • cardiomyopathy, primary prevention ICD

Exclusion criteria

  • brady-pacing requirement

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems